| COVID-19 |
1 |
1 |
| Arthritis |
0 |
0.4 |
| Kidney |
0 |
0.4 |
| Steroids |
0 |
0.4 |
| Renal Disease |
0 |
0.38 |
| Coronary Artery Disease (CAD) |
0 |
0.28 |
| Hospital |
0 |
0.27 |
| Immunization |
0 |
0.27 |
| Renal Failure |
0 |
0.18 |
| Chronic Kidney Disease |
0 |
0.17 |
| Rheumatoid Arthritis |
0 |
0.17 |
| Artery |
0 |
0.13 |
| Clinical Management |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Coagulation |
0 |
0.13 |
| Cytokines |
0 |
0.13 |
| Edema |
0 |
0.13 |
| Electronic Medical Record |
0 |
0.13 |
| Estrogen |
0 |
0.13 |
| Genetics |
0 |
0.13 |
| Geriatrics |
0 |
0.13 |
| Health Equity |
0 |
0.13 |
| Heart |
0 |
0.13 |
| Hyperlipidemia |
0 |
0.13 |
| Lung |
0 |
0.13 |
| Medicaid |
0 |
0.13 |
| New York |
0 |
0.13 |
| Precision Medicine |
0 |
0.13 |
| Rheumatic Disease |
0 |
0.13 |
| Severe Acute Respiratory Syndrome |
0 |
0.13 |
| Shock |
0 |
0.13 |
| Sepsis |
0 |
0.12 |
| Acute Respiratory Distress Syndrome |
0 |
0.11 |
| Cardiometabolic Risk Factors |
0 |
0.1 |
| Electronic Health Record (EHR) |
0 |
0.1 |
| Genomic Medicine |
0 |
0.08 |
| Heart Failure (HF) |
0 |
0.08 |
| Hypertension |
0 |
0.07 |
| Pneumonia |
0 |
0.07 |
| Biologic Therapy |
0 |
0.06 |
| Healthcare and Medical Technology |
0 |
0.04 |
| Lipids Management |
0 |
0.04 |
| Social Determinants of Health |
0 |
0.04 |
| Vaccines |
0 |
0.04 |